KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,680 | -70.3% | 30,200 | -52.3% | 0.01% | -64.7% |
| Q3 2022 | $346,000 | +16.5% | 63,328 | -3.9% | 0.02% | +41.7% |
| Q2 2022 | $297,000 | -62.8% | 65,928 | -39.1% | 0.01% | -58.6% |
| Q1 2022 | $799,000 | +505.3% | 108,228 | +757.1% | 0.03% | +480.0% |
| Q1 2021 | $132,000 | -35.0% | 12,627 | +17.7% | 0.01% | -54.5% |
| Q2 2020 | $203,000 | -81.1% | 10,728 | -80.8% | 0.01% | -87.1% |
| Q1 2020 | $1,072,000 | -42.9% | 55,800 | -43.0% | 0.08% | -18.3% |
| Q4 2019 | $1,878,000 | +255.0% | 97,900 | +78.0% | 0.10% | +205.9% |
| Q3 2019 | $529,000 | – | 55,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |